MedTrace Logo

Analysis of Revascularization in Ischemic Stroke With EmboTrap

NCT02488915 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 228

Last updated 2018-07-13

Study results available
· View outcomes & findings →

Summary

The study objective is to examine the recanalization efficacy of the EmboTrap device and its associated performance characteristics and to record associated clinical outcomes in a manner that facilitates relevant comparison of outputs with that of devices approved in the U.S. for clearing Large Vessel Occlusions.

Conditions

Interventions

DEVICE

EmboTrap® Revascularization Device

Sponsors & Collaborators

  • Neuravi Inc.

    lead INDUSTRY

Principal Investigators

  • Prof. Sam Zaidat, M.D. · St. Vincent Mercy Mercy Hospital, Toledo,Ohio, USA

  • Prof. Tommy Andersson, M.D. · Karolinska Institutet

  • Prof. Jeffery Saver, M.D. · UCLA, CA, USA.

  • Prof. Heinrich Mattle, M.D. · University of Berne, Berne, Switzerland.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-05-31
Completion
2017-09-30

Countries

  • United States
  • Belgium
  • Germany
  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02488915 on ClinicalTrials.gov